FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

3932711000001105: Centyl K modified-release tablets (LEO Pharma) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
18052701000001119 Centyl K modified-release tablets (LEO Pharma) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
18052801000001111 Centyl K modified-release tablets (LEO Pharma) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Centyl K modified-release tablets (LEO Pharma) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Centyl K modified-release tablets (LEO Pharma) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Centyl K modified-release tablets (LEO Pharma) Is a Bendrofluazide+potassium 2.5mg/7.7Mmol m/r tablet false Inferred relationship Existential restriction modifier
Centyl K modified-release tablets (LEO Pharma) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Centyl K modified-release tablets (LEO Pharma) Has excipient Stearyl alcohol false Inferred relationship Existential restriction modifier
Centyl K modified-release tablets (LEO Pharma) Has active ingredient Potassium true Inferred relationship Existential restriction modifier
Centyl K modified-release tablets (LEO Pharma) Has active ingredient Bendroflumethiazide true Inferred relationship Existential restriction modifier
Centyl K modified-release tablets (LEO Pharma) Has active ingredient Bendrofluazide - chemical false Inferred relationship Existential restriction modifier
Centyl K modified-release tablets (LEO Pharma) Has active ingredient Potassium chloride false Inferred relationship Existential restriction modifier
Centyl K modified-release tablets (LEO Pharma) Has active ingredient Potassium chloride false Inferred relationship Existential restriction modifier
Centyl K modified-release tablets (LEO Pharma) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Centyl K modified-release tablets (LEO Pharma) VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Centyl K modified-release tablets (LEO Pharma) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Centyl K modified-release tablets (LEO Pharma) Is a Centyl K true Inferred relationship Existential restriction modifier
Centyl K modified-release tablets (LEO Pharma) Has specific active ingredient Bendroflumethiazide true Inferred relationship Existential restriction modifier
Centyl K modified-release tablets (LEO Pharma) Has specific active ingredient Potassium chloride true Inferred relationship Existential restriction modifier
Centyl K modified-release tablets (LEO Pharma) Has dispensed dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Centyl K modified-release tablets (LEO Pharma) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Centyl K modified-release tablets (LEO Pharma) VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Centyl K modified-release tablets (LEO Pharma) Is a Bendroflumethiazide 2.5mg / Potassium chloride 573mg (potassium 7.7mmol) modified-release tablets false Inferred relationship Existential restriction modifier
Centyl K modified-release tablets (LEO Pharma) Is a Bendroflumethiazide 2.5mg / Potassium chloride 573mg (potassium 7.7mmol) modified-release tablets true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Centyl K modified-release tablets (LEO Pharma) 56 tablet 4 x 14 tablets Is pack of False Centyl K modified-release tablets (LEO Pharma) Inferred relationship Existential restriction modifier
Centyl K modified-release tablets (LEO Pharma) 56 tablet 4 x 14 tablets Has AMP True Centyl K modified-release tablets (LEO Pharma) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start